Fusobacterium nucleatum

From Aaushi
Jump to navigation Jump to search

Epidemiology

Pathology

Management

More general terms

Additional terms

References

  1. 1.0 1.1 Rubinstein MR et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013 Aug 14; 14:195. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23954158
    Kostic AD et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013 Aug 14; 14:207. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23954159
  2. Kostic AD et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012 Feb;22(2):292-8. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22009990 <Internet> http://genome.cshlp.org/content/early/2011/10/04/gr.126573.111
    Castellarin M et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012 Feb;22(2):299-306 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22009989 <Internet> http://genome.cshlp.org/content/early/2011/10/05/gr.126516.111
    Rubinstein MR et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013 Aug 14; 14:195. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23954158
    Kostic AD et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013 Aug 14; 14:207. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23954159
  3. 3.0 3.1 3.2 3.3 Zepeda-Rivera M, Minot SS, Bouzek H et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 2024 Apr 11; 628:424 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38509359 PMCID: PMC11006615 Free PMC article. https://www.nature.com/articles/s41586-024-07182-w